<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Trichomoniasis – One‑Page Clinical Algorithm (NICE CKS, Dec 2024)</title>
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
  <style>
    :root{
      --bg: #0b0d12;
      --panel: #121622;
      --muted: #94a3b8;
      --text: #e5e7eb;
      --brand: #5eead4;
      --brand-2: #93c5fd;
      --danger: #fda4af;
      --warn: #fde68a;
      --ok: #86efac;
      --link: #7dd3fc;
      --border: #1f2937;
      --chip: #0f172a;
    }
    @media (prefers-color-scheme: light){
      :root{
        --bg:#f7fafc; --panel:#ffffff; --muted:#475569; --text:#111827; --brand:#0ea5e9; --brand-2:#22c55e; --danger:#dc2626; --warn:#d97706; --ok:#059669; --link:#2563eb; --border:#e5e7eb; --chip:#f1f5f9;
      }
      .badge.soft { background: #e0f2fe; color:#075985; }
    }
    *{ box-sizing:border-box }
    html,body{ height:100% }
    body{
      margin:0; font-family:Inter, system-ui, -apple-system, Segoe UI, Roboto, "Helvetica Neue", Arial, "Noto Sans", "Apple Color Emoji","Segoe UI Emoji";
      background:radial-gradient(1200px 600px at 20% -10%, rgba(59,130,246,.16), transparent),
                 radial-gradient(900px 500px at 110% 10%, rgba(45,212,191,.14), transparent),
                 var(--bg);
      color:var(--text);
      line-height:1.5;
    }
    .container{ max-width: 1100px; margin: 0 auto; padding: 24px; }

    /* Header */
    .appbar{ position:sticky; top:0; backdrop-filter: blur(10px); background: color-mix(in oklab, var(--bg) 70%, transparent); z-index:10; border-bottom:1px solid var(--border);}  
    .appbar-inner{ display:flex; align-items:center; gap:16px; padding: 12px 24px; }
    .logo{ display:flex; align-items:center; gap:10px; font-weight:700; letter-spacing:.3px }
    .logo .dot{ width:10px; height:10px; background:conic-gradient(from 180deg, var(--brand), var(--brand-2)); border-radius:50%; box-shadow:0 0 14px color-mix(in oklab, var(--brand) 40%, transparent) }
    .nav{ margin-left:auto; display:flex; gap:8px; flex-wrap:wrap }
    .nav a{ text-decoration:none; color:var(--text); opacity:.8; padding:6px 10px; border-radius:10px; border:1px solid transparent }
    .nav a:hover{ border-color:var(--border); opacity:1 }
    .btn{ border:1px solid var(--border); background:linear-gradient(180deg, color-mix(in oklab, var(--panel) 85%, transparent), var(--panel)); padding:8px 12px; border-radius:12px; color:var(--text); cursor:pointer; font-weight:600 }
    .btn:hover{ transform: translateY(-1px); box-shadow:0 6px 20px rgba(0,0,0,.12) }

    /* Hero */
    .hero{ display:grid; grid-template-columns: 1.2fr .8fr; gap:24px; align-items:stretch; }
    @media (max-width: 900px){ .hero{ grid-template-columns: 1fr; } }
    .panel{ background:linear-gradient(180deg, color-mix(in oklab, var(--panel) 92%, transparent), var(--panel)); border:1px solid var(--border); border-radius:18px; padding:22px; }
    .title{ font-size: clamp(24px, 4vw, 38px); line-height:1.15; margin:0 0 10px 0; letter-spacing:.2px }
    .subtitle{ color: var(--muted); margin: 0 0 14px 0 }
    .badges{ display:flex; flex-wrap:wrap; gap:10px; margin: 14px 0 6px }
    .badge{ display:inline-flex; align-items:center; gap:8px; padding:6px 10px; border-radius:999px; font-size:13px; border:1px solid var(--border); background:var(--chip) }
    .badge .dot{ width:7px; height:7px; border-radius:50% }
    .soft{ background: color-mix(in oklab, var(--brand) 16%, var(--chip)); color: color-mix(in oklab, var(--brand) 70%, var(--text)); border-color: color-mix(in oklab, var(--brand) 50%, var(--border)); }

    /* Cards grid */
    .grid{ display:grid; grid-template-columns: repeat(12, 1fr); gap:18px; }
    .card{ grid-column: span 6; background:linear-gradient(180deg, color-mix(in oklab, var(--panel) 94%, transparent), var(--panel)); border:1px solid var(--border); border-radius:16px; padding:18px; }
    .card.full{ grid-column: 1 / -1 }
    .card.thin{ grid-column: span 4 }
    .card h3{ margin:0 0 12px; font-size:18px; letter-spacing:.2px }
    .eyebrow{ text-transform: uppercase; font-weight:700; font-size:12px; color: var(--muted); letter-spacing:.14em; display:block; margin-bottom:6px }
    .list{ margin:0; padding-left:18px }
    .list li{ margin:6px 0; }
    .hint{ color: var(--muted); font-size: 13px }

    .kpi{ display:flex; gap:18px; flex-wrap:wrap }
    .kpi .pill{ border:1px solid var(--border); background:var(--chip); border-radius:999px; padding:8px 12px; font-weight:600; font-size:14px }

    /* Stepper */
    .stepper{ display:flex; gap:14px; flex-wrap:wrap; align-items:flex-start }
    .step{ display:flex; gap:10px; align-items:flex-start; background:var(--chip); border:1px solid var(--border); padding:10px 12px; border-radius:14px }
    .num{ width:22px; height:22px; border-radius:50%; display:grid; place-content:center; background: conic-gradient(from 90deg,var(--brand), var(--brand-2)); color:#0b0d12; font-weight:800 }

    /* Utilities */
    .muted{ color: var(--muted) }
    .small{ font-size: 12px }
    .foot{ margin-top: 12px; }

    /* Print */
    @media print{
      .appbar{ display:none }
      body{ background:#fff; color:#111 }
      .panel, .card{ box-shadow:none; background:#fff; border-color:#ddd }
      .container{ max-width: none; padding: 0 }
      .btn{ display:none }
    }
  </style>
</head>
<body>
  <header class="appbar">
    <div class="appbar-inner">
      <div class="logo">
        <span class="dot" aria-hidden="true"></span>
        Trichomoniasis – One‑Page Algorithm
      </div>
      <nav class="nav" aria-label="In‑page Navigation">
        <a href="#suspect">Suspect & Assess</a>
        <a href="#exam">Exam & Tests</a>
        <a href="#manage">Management</a>
        <a href="#partners">Partners</a>
        <a href="#advice">Advice</a>
        <a href="#follow">Follow‑Up</a>
        <a href="#failure">Tx Failure</a>
        <a href="#safety">Safety</a>
      </nav>
      <button class="btn" onclick="window.print()" title="Print or save as PDF">Print</button>
    </div>
  </header>

  <main class="container">
    <section class="hero" aria-labelledby="page-title">
      <div class="panel">
        <h1 id="page-title" class="title">Trichomoniasis – One‑Page Clinical Algorithm</h1>
        <p class="subtitle">Fast memory aide for diagnosis, management and follow‑up in primary care. Based on NICE CKS (Dec 2024).</p>
        <div class="badges">
          <span class="badge soft"><span class="dot" style="background:var(--brand)"></span> First‑line: Metronidazole 400–500 mg BD × 7 d</span>
          <span class="badge"><span class="dot" style="background:var(--brand-2)"></span> Alternative: 2 g single dose (avoid in pregnancy/breastfeeding)</span>
          <span class="badge"><span class="dot" style="background:var(--ok)"></span> Partners: treat current + last 4 weeks</span>
          <span class="badge"><span class="dot" style="background:var(--warn)"></span> Abstain: ≥1 week after start + until both completed</span>
        </div>
        <div class="kpi" style="margin-top:14px">
          <div class="pill">Age: ≥13 years</div>
          <div class="pill">NAAT preferred</div>
          <div class="pill">Screen for other STIs</div>
          <div class="pill">GUM referral ideal</div>
        </div>
      </div>
      <aside class="panel" aria-label="At‑a‑glance Flow">
        <span class="eyebrow">At‑a‑glance flow</span>
        <div class="stepper">
          <div class="step"><span class="num">1</span> Suspect from symptoms / risks</div>
          <div class="step"><span class="num">2</span> Examine & take samples (NAAT)</div>
          <div class="step"><span class="num">3</span> Treat + screen for other STIs</div>
          <div class="step"><span class="num">4</span> Treat partners (current + 4 w)</div>
          <div class="step"><span class="num">5</span> Counsel & abstinence advice</div>
          <div class="step"><span class="num">6</span> Review; test‑of‑cure if symptomatic</div>
        </div>
        <p class="hint foot">If specialist referral declined/unavailable, manage in primary care and seek advice for complex scenarios (pregnancy, lactation, allergy, HIV with complications).</p>
      </aside>
    </section>

    <!-- Content Grid -->
    <section class="grid" style="margin-top:22px">
      <article id="suspect" class="card">
        <span class="eyebrow">1 · Suspect & Assess</span>
        <h3>Clinical picture & risk assessment</h3>
        <ul class="list">
          <li><strong>Women:</strong> vaginal discharge (frothy yellow‑green in 10–30%), vulval itching, dysuria, odour; ± vulvitis/vaginitis, strawberry cervix (cervicitis).</li>
          <li><strong>Men:</strong> often asymptomatic; urethral discharge (20–60%), dysuria, frequency, irritation; rarely balanitis/balanoposthitis.</li>
          <li><strong>Risk factors:</strong> multiple partners in last year, inconsistent condom use, concurrent GC/CT (women), bacterial vaginosis.</li>
        </ul>
        <p class="hint">Up to 50% of women and 15–50% of men can be asymptomatic.</p>
      </article>

      <article id="exam" class="card">
        <span class="eyebrow">2 · Examination & Testing</span>
        <h3>What to do now</h3>
        <ul class="list">
          <li><strong>Women:</strong> Abdomen PRN; inspect vulva; speculum: look for frothy yellow‑green discharge ± fishy odour; strawberry cervix may be seen; test vaginal pH — <em>&gt;4.5 suggests TV</em>.</li>
          <li><strong>Sampling:</strong> High‑vaginal swab (posterior fornix) for <strong>NAAT (preferred)</strong> ± microscopy/culture if available. Use Amies with charcoal; refrigerate if delay (≤48 h at 4°C).</li>
          <li><strong>Self‑swab:</strong> If microscopy not done, a <em>self‑administered vaginal swab</em> for NAAT is recommended.</li>
          <li><strong>Men:</strong> Urethral or self‑taken penile‑meatal swab for NAAT; signs may be absent despite symptoms of urethritis.</li>
          <li><strong>Also test for:</strong> CT, GC, HIV, syphilis ± hepatitis if high risk.</li>
        </ul>
      </article>

      <article id="manage" class="card full">
        <span class="eyebrow">3 · Management (Primary care if GUM unavailable)</span>
        <h3>Treatment choices</h3>
        <div class="grid" style="grid-template-columns: repeat(12,1fr); gap:14px">
          <div class="panel" style="grid-column: span 6">
            <h4 style="margin:0 0 6px">Adults (not pregnant/breastfeeding)</h4>
            <ul class="list">
              <li><strong>Metronidazole 400–500 mg PO BD × 7 days</strong></li>
              <li>Alternative: <strong>Metronidazole 2 g PO single dose</strong></li>
              <li>Confirmed metronidazole allergy → seek GUM advice</li>
            </ul>
          </div>
          <div class="panel" style="grid-column: span 6">
            <h4 style="margin:0 0 6px">Pregnancy / Breastfeeding</h4>
            <ul class="list">
              <li><strong>Symptomatic:</strong> Metronidazole <strong>400 mg PO BD × 7 days</strong></li>
              <li><strong>Avoid</strong> 2 g single dose during pregnancy/breastfeeding</li>
              <li><strong>Asymptomatic pregnancy:</strong> seek specialist advice</li>
              <li>Inform midwife/obstetrician where relevant</li>
            </ul>
          </div>
          <div class="panel" style="grid-column: span 6">
            <h4 style="margin:0 0 6px">People with HIV</h4>
            <ul class="list">
              <li><strong>Metronidazole 500 mg PO BD × 7 days</strong></li>
              <li>Allergy → seek GUM advice</li>
            </ul>
          </div>
          <div class="panel" style="grid-column: span 6">
            <h4 style="margin:0 0 6px">General steps</h4>
            <ul class="list">
              <li>Provide written info; discuss complications & recurrence risk</li>
              <li>Offer full STI screen (if not already done)</li>
              <li>Arrange follow‑up to review symptoms and contact tracing</li>
            </ul>
          </div>
        </div>
      </article>

      <article id="partners" class="card">
        <span class="eyebrow">4 · Partner Management</span>
        <h3>Treat & screen partners</h3>
        <ul class="list">
          <li>Treat <strong>all current partners</strong> and <strong>any partners in the past 4 weeks</strong>.</li>
          <li>Treat <strong>simultaneously</strong> to prevent reinfection.</li>
          <li>Offer CT/GC/HIV/syphilis testing to partners.</li>
        </ul>
      </article>

      <article id="advice" class="card">
        <span class="eyebrow">5 · Advice to Patients</span>
        <h3>Counselling pearls</h3>
        <ul class="list">
          <li><strong>Abstain from sex</strong> for <strong>≥1 week after starting treatment</strong> <em>and</em> until both patient and partners have completed therapy and follow‑up.</li>
          <li>Possible metronidazole side‑effects (GI upset, metallic taste); avoid alcohol (disulfiram‑like reaction possible) during therapy and for <strong>≥48 h</strong> after last dose.</li>
          <li>Provide links/leaflets (NHS, BASHH).</li>
        </ul>
      </article>

      <article id="follow" class="card">
        <span class="eyebrow">6 · Follow‑Up</span>
        <h3>When & what to review</h3>
        <ul class="list">
          <li>Assess persistent or recurrent symptoms → consider treatment failure or reinfection.</li>
          <li>Confirm contact tracing completed; review STI results.</li>
          <li><strong>Test of cure</strong> only if symptoms persist or recur.</li>
        </ul>
      </article>

      <article id="failure" class="card">
        <span class="eyebrow">7 · If Treatment Failure</span>
        <h3>Before escalating</h3>
        <ul class="list">
          <li>Check adherence and vomiting of doses; review drug interactions.</li>
          <li>Exclude reinfection; ensure partners were treated concurrently.</li>
          <li>Reconsider diagnosis; rule out alternative causes of discharge/urethritis.</li>
          <li>Offer repeat testing (leave ≥48 h after finishing initial treatment).</li>
          <li><strong>Repeat</strong> 7‑day metronidazole (400–500 mg BD) if not pregnant/breastfeeding.</li>
          <li><strong>Refer/seek GUM advice</strong> if repeat regimen fails, if pregnant/breastfeeding, or in confirmed allergy.</li>
        </ul>
      </article>

      <article id="safety" class="card full">
        <span class="eyebrow">Safety · Prescribing Notes (Metronidazole)</span>
        <h3>Contraindications / cautions & interactions</h3>
        <div class="grid" style="grid-template-columns: repeat(12,1fr); gap:14px">
          <div class="panel" style="grid-column: span 6">
            <h4 style="margin:0 0 6px">Contraindications & cautions</h4>
            <ul class="list">
              <li>Hypersensitivity to metronidazole or other nitroimidazoles.</li>
              <li><strong>Cockayne syndrome:</strong> risk of severe hepatotoxicity → use only if essential; monitor LFTs before, during, and after.</li>
              <li>Severe CNS disease (risk of neurological aggravation).</li>
              <li><strong>Hepatic encephalopathy:</strong> consider ~one‑third daily dose given once daily.</li>
            </ul>
          </div>
          <div class="panel" style="grid-column: span 6">
            <h4 style="margin:0 0 6px">Key interactions</h4>
            <ul class="list">
              <li><strong>Alcohol:</strong> possible disulfiram‑like reaction → avoid during and for ≥48 h post‑course.</li>
              <li>Warfarin (↑ anticoagulation) → monitor INR, adjust dose.</li>
              <li>Lithium (↑ levels) → consider dose reduction; monitor levels, creatinine, electrolytes.</li>
              <li>Phenytoin/phenobarbital (↑ MTZ metabolism) → effect may be reduced.</li>
              <li>Ciclosporin (↑ levels) → monitor drug level & creatinine.</li>
              <li>Fluorouracil (↑ toxicity), busulfan (↑ toxicity) → monitor closely/avoid high doses.</li>
              <li>Ergot derivatives (risk of ergotism) → avoid/monitor; stop if symptoms.</li>
              <li>Live cholera & typhoid vaccines → avoid within recommended windows.</li>
            </ul>
          </div>
          <div class="panel" style="grid-column: span 12">
            <h4 style="margin:0 0 6px">Pregnancy & Breastfeeding</h4>
            <ul class="list">
              <li>Widely used in pregnancy; data do not indicate ↑ congenital malformation; manufacturer advises use only if essential.</li>
              <li><strong>Avoid</strong> short high‑dose (2 g single) regimens in pregnancy/breastfeeding.</li>
              <li>Significant drug passes into milk and may impart bitter taste.</li>
            </ul>
            <p class="hint">For pregnant or breastfeeding patients needing further therapy after first‑line, seek GUM/obstetric advice.</p>
          </div>
        </div>
      </article>

      <article class="card thin">
        <span class="eyebrow">Reminders</span>
        <h3>Also consider / rule out</h3>
        <ul class="list">
          <li>BV, vulvovaginal candidiasis, CT/GC, PID</li>
          <li>Non‑infective causes: foreign body, irritant/allergic vaginitis, GSM, dermatological and malignant causes as per history/exam</li>
        </ul>
      </article>

      <article class="card thin">
        <span class="eyebrow">Documentation</span>
        <h3>Record</h3>
        <ul class="list">
          <li>Symptoms, duration, sexual history, partner details (last 4 weeks)</li>
          <li>Examination findings, pH, tests sent and results</li>
          <li>Regimen, counselling given, partner notification plan</li>
        </ul>
      </article>

      <article class="card thin">
        <span class="eyebrow">Practical</span>
        <h3>Logistics</h3>
        <ul class="list">
          <li>Mark lab request “suspected trichomoniasis”; ensure transport & storage conditions are met</li>
          <li>If microscopy unavailable → self vaginal swab NAAT (women) / penile‑meatal NAAT (men)</li>
        </ul>
      </article>

      <article class="card full" style="display:flex; align-items:center; justify-content:space-between; gap:12px">
        <div>
          <strong>Source:</strong> NICE Clinical Knowledge Summaries – Trichomoniasis (last revised Dec 2024). This page condenses the guidance for rapid clinical decision‑making.
          <div class="muted small foot">Intended for healthcare professionals. Does not replace specialist advice. Check local pathways & formularies.</div>
        </div>
        <button class="btn" onclick="window.print()">Print / Save PDF</button>
      </article>
    </section>
  </main>
</body>
</html>